|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | St. Jude Medical, Inc. (NYSE:STJ, a manufacturer of cardiovascular medical devices. |
|---|---|
| Transferring Party | Savacor, Inc., a developer of heart failure diagnostic and therapy guidance products and technologies in clinical evaluation. |
| Sector | Medical Devices |
| Date | January 3, 2006 |
| Analysis Savacor's small implantable sensor, in clinical trials, measures left atrial pressure and body temperature to help physicians detect and manage symptoms associated with progressive heart failure. The deal, valued at $50m plus possible milestone payments, complements St. Jude's development efforts in managing the co-morbidities of heart failure patients. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |